NASDAQ · Biotechnology

Soligenix Inc. (SNGX)

$0.22 -8.29%
21 Oversold Daily RSI (14) · 18 Nov 2026

Moving averages

SMA 200$0.63-65.06%

Company profile

Soligenix, Inc., an advanced stage biopharmaceutical company, focuses on developing and marketing products to treat rare diseases in the United States. The company is headquartered in Princeton, New Jersey.

SectorHealthcare
IndustryBiotechnology
Market cap$7.50M
P/E ratioNone
EPS$-0.21
Beta2.042
Dividend yield0.00%
52-week high$1.70
52-week low$0.27

Similar stocks in Biotechnology

30 days of PRO Unlimited free, no card

RSI alerts for SNGX

An email when SNGX closes below RSI 30 or above 70. Nothing else.

Data last updated 17 November 2026 at 1:04 AM EST